
Grace Therapeutics, Inc.
GRCEHealthcare|Biotechnology|US
$1.85
+0.07 (+3.93%)
DCF Value
$0.70
Tangible Book / Share
$0.72
Cash / Share
$0.80
Ownership Breakdown
83.5%
Float
16.3M
Shares Outstanding
13.6M
Float Shares
Major Holders (14)
Combined: 122.4%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Opaleye, L.P. | Partnership | 13.07% | 2,748,392 | Aug 7, 2026 | 13D/G |
| Opaleye Management Inc. | IA, CO | 13.07% | 2,748,392 | Aug 7, 2026 | 13D/G |
| James Silverman | Individual | 13.07% | 2,748,392 | Aug 7, 2026 | 13D/G |
| ADAR1 Capital Management, LLC | IA, OO | 9.90% | 1,806,216 | Aug 14, 2026 | 13D/G |
| Daniel Schneeberger | HC, IN | 9.90% | 1,806,216 | Aug 14, 2026 | 13D/G |
| Hirschman Orin | HC, IN | 9.90% | 1,322,379 | May 8, 2025 | 13D/G |
| AIGH Capital Management, LLC | IA, OO | 9.90% | 1,322,379 | May 8, 2025 | 13D/G |
| ADAR1 Capital Management GP, LLC | Other | 8.60% | 1,525,757 | Aug 14, 2026 | 13D/G |
| Nantahala Capital Management, LLC | Investment adviser | 6.75% | 1,178,203 | Aug 14, 2026 | 13D/G |
| Daniel Mack | Holding company | 6.75% | 1,178,203 | Aug 14, 2026 | 13D/G |
| Wilmot B. Harkey | Holding company | 6.75% | 1,178,203 | Aug 14, 2026 | 13D/G |
| AIGH Capital Management LLC | IA, OO | 4.90% | 814,000 | Apr 27, 2026 | 13D/G |
| Orin Hirschman | HC, IN | 4.90% | 814,000 | Apr 27, 2026 | 13D/G |
| Bank of America Corp /De/ | Holding company | 4.90% | 494,698 | Nov 14, 2024 | 13D/G |
Insider Trades (45)
Last 4 quarters: 1,274,950 acquired · 0 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10 percent owner | Nov 5, 2026 | BUY | 3,087 | $1.77 | $5.5K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Nov 4, 2026 | BUY | 5,027 | $1.80 | $9.1K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Nov 3, 2026 | BUY | 10,328 | $1.79 | $18.5K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Oct 26, 2026 | BUY | 66,411 | $1.77 | $117.4K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Oct 22, 2026 | BUY | 21,390 | $1.93 | $41.2K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Oct 19, 2026 | BUY | 4,256 | $1.88 | $8.0K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Oct 16, 2026 | BUY | 36,347 | $1.89 | $68.8K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Oct 15, 2026 | BUY | 23,485 | $1.95 | $45.7K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Oct 14, 2026 | BUY | 11,233 | $1.93 | $21.7K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Oct 12, 2026 | BUY | 7,215 | $2.02 | $14.6K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Oct 9, 2026 | BUY | 5,340 | $2.04 | $10.9K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Oct 8, 2026 | BUY | 2,077 | $2.02 | $4.2K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Oct 5, 2026 | BUY | 1,694 | $2.06 | $3.5K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Oct 2, 2026 | BUY | 20,000 | $2.07 | $41.4K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Oct 1, 2026 | BUY | 38,796 | $2.04 | $79.0K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Sep 29, 2026 | BUY | 7,849 | $2.09 | $16.4K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Sep 23, 2026 | BUY | 5,318 | $2.10 | $11.2K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Sep 21, 2026 | BUY | 9,771 | $2.10 | $20.5K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Sep 23, 2026 | BUY | 5,318 | $2.10 | $11.2K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Sep 21, 2026 | BUY | 9,771 | $2.10 | $20.5K | Form 4 |
| NEUGEBOREN EDWARD | director | Sep 17, 2026 | AWARD | 12,200 | $2.13 | $26.0K | Form 4 |
| DAVIS A BRIAN | director | Sep 17, 2026 | AWARD | 0 | $2.13 | — | Form 4 |
| Kavuru Vimal | director | Sep 17, 2026 | AWARD | 12,200 | $2.13 | $26.0K | Form 4 |
| Kottayil George | director | Sep 17, 2026 | AWARD | 12,200 | $2.13 | $26.0K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Sep 9, 2026 | BUY | 5,836 | $2.09 | $12.2K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Sep 8, 2026 | BUY | 9,393 | $2.10 | $19.7K | Form 4 |
| Kohli Prashant | director, officer: Chief Executive Officer | Sep 9, 2026 | BUY | 100,000 | $2.14 | $214.0K | Form 4 |
| Kumar Amresh | VP Program Management | Aug 28, 2026 | AWARD | 35,760 | $2.12 | $75.8K | Form 4 |
| Kohli Prashant | director, officer: Chief Executive Officer | Aug 28, 2026 | AWARD | 267,160 | $2.12 | $566.4K | Form 4 |
| Macdonald R. Loch | Chief Medical Officer | Aug 28, 2026 | AWARD | 54,690 | $2.12 | $115.9K | Form 4 |
| DelAversano Robert J | Principal Financial Officer | Aug 28, 2026 | AWARD | 33,660 | $2.12 | $71.4K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Aug 14, 2026 | BUY | 11,608 | $2.09 | $24.2K | Form 4 |
| Kavuru Vimal | director | Jan 8, 2026 | AWARD | 10,000 | $3.80 | $38.0K | Form 4 |
| Kottayil George | director | Jan 8, 2026 | AWARD | 10,000 | $3.80 | $38.0K | Form 4 |
| NEUGEBOREN EDWARD | director | Jan 8, 2026 | AWARD | 10,000 | $3.80 | $38.0K | Form 4 |
| DAVIS A BRIAN | director | Jan 8, 2026 | AWARD | 10,000 | $3.80 | $38.0K | Form 4 |
| Kottayil George | director | May 9, 2025 | AWARD | 10,000 | $2.72 | $27.2K | Form 4 |
| NEUGEBOREN EDWARD | director | May 9, 2025 | AWARD | 10,000 | $2.72 | $27.2K | Form 4 |
| DAVIS A BRIAN | director | May 9, 2025 | AWARD | 10,000 | $2.72 | $27.2K | Form 4 |
| Kavuru Vimal | director | May 9, 2025 | AWARD | 10,000 | $2.72 | $27.2K | Form 4 |
| Kumar Amresh | VP Program Management | Apr 14, 2025 | AWARD | 30,000 | $2.08 | $62.4K | Form 4 |
| Macdonald R. Loch | Chief Medical Officer | Apr 14, 2025 | AWARD | 40,000 | $2.08 | $83.2K | Form 4 |
| DelAversano Robert J | Principal Financial Officer | Apr 14, 2025 | AWARD | 20,130 | $2.08 | $41.9K | Form 4 |
| Kohli Prashant | director, officer: Chief Executive Officer | Apr 14, 2025 | AWARD | 225,400 | $2.08 | $468.8K | Form 4 |
| D'Andrea Carrie | VP Clinical Operations | Apr 14, 2025 | AWARD | 30,000 | $2.08 | $62.4K | Form 4 |